HB
AGN

Homrich & Berg’s Allergan plc AGN Stock Holding History

Homrich & Berg’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,472
Closed -$507K – 374
2017
Q3 		$507K Buy
+2,472
New +$575K 0.04% 188
2017
Q2 		– Sell
-1,283
Closed -$307K – 316
2017
Q1 		$307K Buy
1,283
+230
+22% +$53.6K 0.03% 232
2016
Q4 		$221K Sell
1,053
-323
-23% -$66.9K 0.02% 254
2016
Q3 		$317K Sell
1,376
-16
-1% -$3.91K 0.03% 203
2016
Q2 		$322K Buy
+1,392
New +$321K 0.03% 190

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Homrich & Berg's AGN Position: Q4 2017 in Review

Homrich & Berg sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 2,472 shares — an estimated $507K sold.

Homrich & Berg first reported a position in AGN in Q2 2016 and held it in 5 quarters. The position peaked at $507K in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Homrich & Berg reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Homrich & Berg sold 2,472 Allergan plc shares in Q4 2017, an estimated $507K.
  • Homrich & Berg first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • Homrich & Berg's Allergan plc position peaked at $507K in Q3 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Homrich & Berg's 13F filing for Q4 2017, filed 9 Feb 2018.